» Articles » PMID: 22160693

Imaging Dynamic Insulin Release Using a Fluorescent Zinc Indicator for Monitoring Induced Exocytotic Release (ZIMIR)

Overview
Specialty Science
Date 2011 Dec 14
PMID 22160693
Citations 71
Authors
Affiliations
Soon will be listed here.
Abstract

Current methods of monitoring insulin secretion lack the required spatial and temporal resolution to adequately map the dynamics of exocytosis of native insulin granules in intact cell populations in three dimensions. Exploiting the fact that insulin granules contain a high level of Zn(2+), and that Zn(2+) is coreleased with insulin during secretion, we have developed a fluorescent, cell surface-targeted zinc indicator for monitoring induced exocytotic release (ZIMIR). ZIMIR displayed a robust fluorescence enhancement on Zn(2+) chelation and bound Zn(2+) with high selectivity against Ca(2+) and Mg(2+). When added to cultured β cells or intact pancreatic islets at low micromolar concentrations, ZIMIR labeled cells rapidly, noninvasively, and stably, and it reliably reported changes in Zn(2+) concentration near the sites of granule fusion with high sensitivity that correlated well with membrane capacitance measurement. Fluorescence imaging of ZIMIR-labeled β cells followed the dynamics of exocytotic activity at subcellular resolution, even when using simple epifluorescence microscopy, and located the chief sites of insulin release to intercellular junctions. Moreover, ZIMIR imaging of intact rat islets revealed that Zn(2+)/insulin release occurred largely in small groups of adjacent β cells, with each forming a "secretory unit." Concurrent imaging of ZIMIR and Fura-2 showed that the amplitude of cytosolic Ca(2+) elevation did not necessarily correlate with insulin secretion activity, suggesting that events downstream of Ca(2+) signaling underlie the cell-cell heterogeneity in insulin release. In addition to studying stimulation-secretion coupling in cells with Zn(2+)-containing granules, ZIMIR may find applications in β-cell engineering and screening for molecules regulating insulin secretion on high-throughput platforms.

Citing Articles

Reversible fluorescent solid porous films for detection of zinc ions in biological media.

Gandin A, Brigo L, Giacomazzo S, Torresan V, Brusatin G, Franco A J Biol Eng. 2025; 19(1):17.

PMID: 39966905 PMC: 11837437. DOI: 10.1186/s13036-025-00484-1.


Biphasic glucose-stimulated insulin secretion over decades: a journey from measurements and modeling to mechanistic insights.

Peng X, Wang K, Chen L Life Metab. 2025; 4(1):loae038.

PMID: 39872989 PMC: 11770817. DOI: 10.1093/lifemeta/loae038.


Impact of dietary zinc on stimulated zinc secretion MRI in the healthy and malignant mouse prostate.

Clavijo Jordan V, Martins A, Dao E, Geraki K, Chirayil S, Wen X Npj Imaging. 2024; 2(1):47.

PMID: 39525279 PMC: 11541085. DOI: 10.1038/s44303-024-00051-1.


Bibliometric analysis of research on the utilization of nanotechnology in diabetes mellitus and its complications.

Zhang J, He M, Gao G, Sun T Nanomedicine (Lond). 2024; 19(16):1449-1469.

PMID: 39121376 PMC: 11318711. DOI: 10.1080/17435889.2024.2358741.


Exploring pancreatic beta-cell subgroups and their connectivity.

Rutter G, Gresch A, Delgadillo Silva L, Benninger R Nat Metab. 2024; 6(11):2039-2053.

PMID: 39117960 DOI: 10.1038/s42255-024-01097-6.


References
1.
Dakin K, Li W . Cell membrane permeable esters of D-myo-inositol 1,4,5-trisphosphate. Cell Calcium. 2007; 42(3):291-301. DOI: 10.1016/j.ceca.2006.12.003. View

2.
Tomat E, Lippard S . Imaging mobile zinc in biology. Curr Opin Chem Biol. 2010; 14(2):225-30. PMC: 2847655. DOI: 10.1016/j.cbpa.2009.12.010. View

3.
Frederickson C, Koh J, Bush A . The neurobiology of zinc in health and disease. Nat Rev Neurosci. 2005; 6(6):449-62. DOI: 10.1038/nrn1671. View

4.
KIEKENS R, In t Veld P, Mahler T, Schuit F, Van De Winkel M, Pipeleers D . Differences in glucose recognition by individual rat pancreatic B cells are associated with intercellular differences in glucose-induced biosynthetic activity. J Clin Invest. 1992; 89(1):117-25. PMC: 442826. DOI: 10.1172/JCI115551. View

5.
Kahn S, Zraika S, Utzschneider K, Hull R . The beta cell lesion in type 2 diabetes: there has to be a primary functional abnormality. Diabetologia. 2009; 52(6):1003-12. PMC: 2737455. DOI: 10.1007/s00125-009-1321-z. View